Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1

Molecular Immunology

Volumn 42, Issue 4 SPEC. ISS., 2005, Pages 433-444

  Demarco, Richard A ^a   Fink, Mitchell P ^b   Lotze, Michael T ^a  

^a Department of Neuroscience   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

HMGB1; Inflammation; Interferon gamma; Interleukin 12; Interleukin 2; Macrophages; Monocytes; Necrosis; NK cells; Tumor immunology; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; INFLAMMATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

EID: 10644274525     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.07.023     Document Type: Short Survey

References (130)

1. R. Abe, T. Shimizu, H. Sugawara, H. Watanabe, H. Nakamura, H. Choei, N. Sasaki, S. Yamagishi, M. Takeuchi, and H. Shimizu Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions J. Invest. Dermatol. 122 2004 461 467
2. R. Abe, T. Shimizu, H. Sugawara, H. Watanabe, H. Nakamura, H. Choei, N. Sasaki, S.-I. Yamagishi, M. Takeuchi, and H. Shimizu Regulation of human melanoma growth and metastasis by age-age receptor interactions J. Invest. Dermatol. 122 2004 461 467
3. S.P. Adams, S.S. Sahota, A. Mijovic, B. Czepulkowski, R.A. Padua, G.J. Mufti, and B.A. Guinn Frequent expression of HAGE in presentation chronic myeloid leukaemias Leukemia 16 2002 2238 2242
4. D. Agnello, H. Wang, H. Yang, K.J. Tracey, and P. Ghezzi HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion Cytokine 18 2002 231 236
5. U. Andersson, and K.J. Tracey HMGB1 in sepsis Scand. J. Infect. Dis. 35 2003 577 584
6. U. Andersson, H. Wang, K. Palmblad, A.C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K.J. Tracey High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J. Exp. Med. 192 2000 565 570
7. U.G. Andersson, and K.J. Tracey HMGB1, a pro-inflammatory cytokine of clinical interest: introduction J. Intern. Med. 255 2004 318 319
8. G. Angelini, S. Gardella, M. Ardy, M.R. Ciriolo, G. Filomeni, G. Di Trapani, F. Clarke, R. Sitia, and A. Rubartelli Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation Proc. Natl. Acad. Sci. U.S.A. 99 2002 1491 1496
9. T. Arumugam, D.M. Simeone, A.M. Schmidt, and C.D. Logsdon S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) J. Biol. Chem. 279 2004 5059 5065
10. M.L. Belladonna, J.C. Renauld, R. Bianchi, C. Vacca, F. Fallarino, C. Orabona, M.C. Fioretti, U. Grohmann, and P. Puccetti IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells J. Immunol. 168 2002 5448 5454
11. N. Bendriss-Vermare, C. Barthelemy, I. Durand, C. Bruand, C. Dezutter-Dambuyant, N. Moulian, S. Berrih-Aknin, C. Caux, G. Trinchieri, and F. Briere Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells J. Clin. Invest. 107 2001 835 844
12. M.E. Bianchi, M. Beltrame, and G. Paonessa Specific recognition of cruciform DNA by nuclear protein HMG1 Science 243 1989 1056 1059
13. M.E. Bianchi, and A. Manfredi Chromatin and cell death Biochim. Biophys. Acta 1677 2004 181 186
14. C.A. Biron Cytokines in the generation of immune responses to, and resolution of, virus infection Curr. Opin. Immunol. 6 1994 530 538
15. T. Bonaldi, F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M.E. Bianchi Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO J. 22 2003 5551 5560
16. L.G. Bucciarelli, T. Wendt, L. Rong, E. Lalla, M.A. Hofmann, M.T. Goova, A. Taguchi, S.F. Yan, S.D. Yan, D.M. Stern, and A.M. Schmidt RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease Cell Mol. Life Sci. 59 2002 1117 1128
17. A.P. Burke, F.D. Kolodgie, A. Zieske, D.R. Fowler, D.K. Weber, P.J. Varghese, A. Farb, and R. Virmani Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler. Thromb. Vasc. Biol. 24 7 2004 1266 1271
18. M. Bustin At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1 Sci. STKE 151 2002 PE39
19. W. Chen, S. Antonenko, J.M. Sederstrom, X. Liang, A.S. Chan, H. Kanzler, B. Blom, B.R. Blazar, and Y.J. Liu Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors Blood 103 7 2004 2547 2553
20. F. Cipollone, A. Iezzi, M. Fazia, M. Zucchelli, B. Pini, C. Cuccurullo, D. De Cesare, G. De Blasis, R. Muraro, R. Bei, F. Chiarelli, A.M. Schmidt, F. Cuccurullo, and A. Mezzetti The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108 2003 1070 1077
21. R. Cordoba-Rodriguez, and D.M. Frucht IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics Expert Opin. Biol. Ther. 3 2003 715 723
22. J. Dai, B. Liu, M.M. Caudill, H. Zheng, Y. Qiao, E.R. Podack, and Z. Li Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory Cancer Immunol. 3 2003 1
23. Y.P. Di, E.A. Repasky, and J.R. Subjeck Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure J. Cell. Physiol. 172 1997 44 54
24. A. Diefenbach, A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages Nat. Immunol. 1 2000 119 126
25. A. Diefenbach, E.R. Jensen, A.M. Jamieson, and D.H. Raulet Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 413 2001 165 171
26. A. Diefenbach, and D.H. Raulet Strategies for target cell recognition by natural killer cells Immunol. Rev. 181 2001 170 184
27. A. Diefenbach, and D.H. Raulet The innate immune response to tumors and its role in the induction of T-cell immunity Immunol. Rev. 188 2002 9 21
28. A. Diefenbach, E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nat. Immunol. 11 2002 11
29. A. Diefenbach, E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet Corrigendum: selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nat. Immunol. 5 2004 658
30. J.Y. Djeu, J.A. Heinbaugh, W.D. Vieira, H.T. Holden, and R.B. Herberman The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C Immunopharmacology 1 1979 231 244
31. H. Donaghy, B. Gazzard, F. Gotch, and S. Patterson Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1 Blood 101 2003 4505 4511
32. S. Eichmuller, D. Usener, A. Jochim, and D. Schadendorf mRNA expression of tumor-associated antigens in melanoma tissues and cell lines Exp. Dermatol. 11 2002 292 301
33. L. Einck, and M. Bustin Inhibition of transcription in somatic cells by microinjection of antibodies to chromosomal proteins Proc. Natl. Acad. Sci. U.S.A. 80 1983 6735 6739
34. L. Einck, and M. Bustin The intracellular distribution and function of the high mobility group chromosomal proteins Exp. Cell. Res. 156 1985 295 310
35. G. Ferlazzo, B. Morandi, A. D'Agostino, R. Meazza, G. Melioli, A. Moretta, and L. Moretta The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells Eur. J. Immunol. 33 2003 306 313
36. G. Ferlazzo, M.L. Tsang, L. Moretta, G. Melioli, R.M. Steinman, and C. Munz Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells J. Exp. Med. 195 2002 343 351
37. N.C. Fernandez, C. Flament, F. Crepineau, E. Angevin, E. Vivier, and L. Zitvogel Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk Eur. Cytokine Netw. 13 2002 17 27
38. N.C. Fernandez, A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo Nat. Med. 5 1999 405 411
39. C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J.H. Shelhamer, and A.F. Suffredini Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652 2660
40. S. Gardella, C. Andrei, S. Costigliolo, L. Olcese, M.R. Zocchi, and A. Rubartelli Secretion of bioactive interleukin-1beta by dendritic cells is modulated by interaction with antigen specific T cells Blood 95 2000 3809 3815
41. S. Gardella, C. Andrei, D. Ferrera, L.V. Lotti, M.R. Torrisi, M.E. Bianchi, and A. Rubartelli The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway EMBO Rep. 3 2002 995 1001
42. S. Gardella, C. Andrei, L.V. Lotti, A. Poggi, M.R. Torrisi, M.R. Zocchi, and A. Rubartelli CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D Blood 98 2001 2152 2159
43. S. Gardella, C. Andrei, A. Poggi, M.R. Zocchi, and A. Rubartelli Control of interleukin-18 secretion by dendritic cells: role of calcium influxes FEBS Lett. 481 2000 245 248
44. A.B. Geldhof, J.A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation Blood 100 2002 4049 4058
45. A. Gerhardt, D. Usener, M. Keese, J. Sturm, D. Schadendorf, and S. Eichmuller Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer Cancer Lett. 208 2004 197 206
46. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri Reciprocal activating interaction between natural killer cells and dendritic cells J. Exp. Med. 195 2002 327 333
47. C.J. Godshall, M.J. Scott, P.T. Burch, J.C. Peyton, and W.G. Cheadle Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages Shock 19 2003 144 149
48. N. Gokden, P. Mukunyadzi, J.D. James, and M. Gokden Diagnostic utility of renal cell carcinoma marker in cytopathology Appl. Immunohistochem. Mol. Morphol. 11 2003 116 119
49. J. Golab, Zagozdzon, T. Stoklosal, R. Kaminski, K. Kozar, and M. Jakobisiak Direct stimulation of macrophages by IL-12 and IL-18 - a bridge too far? Immunol. Lett. 72 2000 153 157
50. S.J. Ha, D.J. Kim, K.H. Baek, Y.D. Yun, and Y.C. Sung IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization J. Immunol. 172 2004 525 531
51. J.A. Hamerman, K. Ogasawara, and L.L. Lanier Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor J. Immunol. 172 2004 2001 2005
52. E. Hartmann, B. Wollenberg, S. Rothenfusser, M. Wagner, D. Wellisch, B. Mack, T. Giese, O. Gires, S. Endres, and G. Hartmann Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer Cancer Res. 63 2003 6478 6487
53. Y. Hayakawa, V. Screpanti, H. Yagita, A. Grandien, H.G. Ljunggren, M.J. Smyth, and B.J. Chambers NK cell trail eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy J. Immunol. 172 2004 123 129
54. K.E. Hellstrom, and I. Hellstrom Therapeutic vaccination with tumor cells that engage CD137 J. Mol. Med. 81 2003 71 86
55. K. Hirata, M. Takada, Y. Suzuki, and Y. Kuroda Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells Hepatogastroenterology 50 2003 1205 1207
56. F.F. Hou, T. Miyata, J. Boyce, Q. Yuan, G.M. Chertow, J. Kay, A.M. Schmidt, and W.F. Owen beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis Kidney Int. 59 2001 990 1002
57. H.L. Hsieh, B.W. Schafer, N. Sasaki, and C.W. Heizmann Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays Biochem. Biophys. Res. Commun. 307 2003 375 381
58. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res. 62 2002 4805 4811
59. K. Ichikawa, M. Yoshinari, M. Iwase, M. Wakisaka, Y. Doi, K. Iino, M. Yamamoto, and M. Fujishima Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients Atherosclerosis 136 1998 281 287
60. J.B. Jackson, and R.L. Rill Circular dichroism, thermal denaturation, and deoxyribonuclease I digestion studies of nucleosomes highly enriched in high mobility group proteins HMG 1 and HMG 2 Biochemistry 20 1981 1042 1046
61. P. Kalinski, P. Vieira, J.H. Schuitemaker, Q. Cai, and M. Kapsenberg Generation of human type 1- and type 2-polarized dendritic cells from peripheral blood Meth. Mol. Biol. 215 2003 427 436
62. A. Kaser, S. Kaser, N.C. Kaneider, B. Enrich, C.J. Wiedermann, and H. Tilg Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression Blood 103 2004 648 655
63. R. Kokkola, J. Li, E. Sundberg, A.C. Aveberger, K. Palmblad, H. Yang, K.J. Tracey, U. Andersson, and H.E. Harris Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity Arthritis Rheum. 48 2003 2052 2058
64. A. Krug, R. Veeraswamy, A. Pekosz, O. Kanagawa, E.R. Unanue, M. Colonna, and M. Cella Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells J. Exp. Med. 197 2003 899 906
65. H. Kuniyasu, Y. Chihara, and H. Kondo Differential effects between amphoterin and advanced glycation end products on colon cancer cells Int. J. Cancer 104 2003 722 727
66. H. Kuniyasu, Y. Chihara, H. Kondo, H. Ohmori, and R. Ukai Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer Oncol. Rep. 10 2003 1863 1868
67. H. Kuniyasu, N. Oue, A. Wakikawa, H. Shigeishi, N. Matsutani, K. Kuraoka, R. Ito, H. Yokozaki, and W. Yasui Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer J. Pathol. 196 2002 163 170
68. G.H. Leder, M. Oppenheim, M. Rosenstein, M.T. Lotze, and H.G. Beger Addition of interleukin 12 to low dose interleukin 2 treatment improves antitumor efficacy in vivo Z. Gastroenterol. 33 1995 499 502
69. J. Li, R. Kokkola, S. Tabibzadeh, R. Yang, M. Ochani, X. Qiang, H.E. Harris, C.J. Czura, H. Wang, L. Ulloa, H.S. Warren, L.L. Moldawer, M.P. Fink, U. Andersson, K.J. Tracey, and H. Yang Structural basis for the proinflammatory cytokine activity of high mobility group box 1 Mol. Med. 9 2003 37 45
70. J. Li, X. Qu, and A.M. Schmidt Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells J. Biol. Chem. 273 1998 30870 30878
71. M.T. Lotze, and R.A. DeMarco Dealing with death: HMGB1 as a novel target for cancer therapy Curr. Opin. Invest. Drugs 12 2003 1405 1409
72. M.T. Lotze, B. Hellerstedt, L. Stolinski, T. Tueting, C. Wilson, D. Kinzler, H. Vu, J.T. Rubin, W. Storkus, H. Tahara, E. Elder, and T. Whiteside The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy Cancer J. Sci. Am. 3 1997 S109 S114
73. M.T. Lotze, M. Shurin, C. Esche, H. Tahara, W. Storkus, J.M. Kirkwood, T.L. Whiteside, E.M. Elder, H. Okada, and P. Robbins Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity Cancer J. Sci. Am. 6 2000 61 66
74. M.J. Loza, and B. Perussia The IL-12 signature: NK cell terminal CD56(+high) stage and effector functions J. Immunol. 172 2004 88 96
75. R.B. Mailliard, Y.I. Son, R. Redlinger, P.T. Coates, A. Giermasz, P.A. Morel, W.J. Storkus, and P. Kalinski Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function J. Immunol. 171 2003 2366 2373
76. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23 2002 549 555
77. H. Matsuda, T. Suda, H. Hashizume, K. Yokomura, K. Asada, K. Suzuki, K. Chida, and H. Nakamura Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma Am. J. Respir. Crit. Care Med. 166 2002 1050 1054
78. S. Miki, S. Kasayama, Y. Miki, Y. Nakamura, M. Yamamoto, B. Sato, and T. Kishimoto Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro Biochem. Biophys. Res. Commun. 196 1993 984 989
79. D.G. Millar, K.M. Garza, B. Odermatt, A.R. Elford, N. Ono, Z. Li, and P.S. Ohashi Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo Nat. Med. 9 2003 1469 1476
80. R. Mocikat, H. Braumuller, A. Gumy, O. Egeter, H. Ziegler, U. Reusch, A. Bubeck, J. Louis, R. Mailhammer, G. Riethmuller, U. Koszinowski, and M. Rocken Natural killer cells activated by MHC class I (low) targets prime dendritic cells to induce protective CD8 T cell responses Immunity 19 2003 561 569
81. A. Moretta Natural killer cells and dendritic cells: rendezvous in abused tissues Nat. Rev. Immunol. 2 2002 957 964
82. L. Moretta, G. Ferlazzo, M.C. Mingari, G. Melioli, and A. Moretta Human natural killer cell function and their interactions with dendritic cells Vaccine 21 2003 S38 S42
83. G. Multhoff Activation of natural killer cells by heat shock protein 70 Int. J. Hyperthermia 18 2002 576 585
84. M. Munder, M. Mallo, K. Eichmann, and M. Modolell Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation J. Exp. Med. 187 1998 2103 2108
85. N. Nagy, C. Brenner, N. Markadieu, C. Chaboteaux, I. Camby, B.W. Schafer, R. Pochet, C.W. Heizmann, I. Salmon, R. Kiss, and C. Decaestecker S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration Lab. Invest. 81 2001 599 612
86. E. Noessner, R. Gastpar, V. Milani, A. Brandl, P.J. Hutzler, M.C. Kuppner, M. Roos, E. Kremmer, A. Asea, S.K. Calderwood, and R.D. Issels Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells J. Immunol. 169 2002 5424 5432
87. B. Oppmann, R. Lesley, B. Blom, J.C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J.S. Abrams, K.W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J.F. Bazan, and R.A. Kastelein Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 2000 715 725
88. J.S. Orange, T.P. Salazar-Mather, S.M. Opal, R.L. Spencer, A.H. Miller, B.S. McEwen, and C.A. Biron Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids J. Exp. Med. 181 1995 901 914
89. T. Osaki, W. Hashimoto, A. Gambotto, H. Okamura, P.D. Robbins, M. Kurimoto, M.T. Lotze, and H. Tahara Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18) Gene Ther. 6 1999 808 815
90. T. Otani, S. Nakamura, M. Toki, R. Motoda, M. Kurimoto, and K. Orita Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice Cell Immunol. 198 1999 111 119
91. I. Pappo, H. Tahara, P.D. Robbins, M.K. Gately, S.F. Wolf, A. Barnea, and M.T. Lotze Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy J. Surg. Res. 58 1995 218 226
92. J.S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J. Biol. Chem. 279 2004 7370 7377
93. J.M. Peron, C. Esche, V.M. Subbotin, C. Maliszewski, M.T. Lotze, and M.R. Shurin FLT3-ligand administration inhibits liver metastases: role of NK cells J. Immunol. 161 1998 6164 6170
94. A. Poggi, R. Carosio, G.M. Spaggiari, C. Fortis, G. Tambussi, G. Dell'Antonio, E. Dal Cin, A. Rubartelli, and M.R. Zocchi NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase. II. Inhibition by HIV-1 Tat C-terminal domain J. Immunol. 168 2002 95 101
95. P. Puccetti, M.L. Belladonna, and U. Grohmann Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity Crit. Rev. Immunol. 22 2002 373 390
96. B. Rendon-Mitchell, M. Ochani, J. Li, J. Han, H. Wang, H. Yang, S. Susarla, C. Czura, R.A. Mitchell, G. Chen, A.E. Sama, and K.J. Tracey IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J. Immunol. 170 2003 3890 3897
97. A. Rouhiainen, J. Kuja-Panula, E. Wilkman, J. Pakkanen, J. Stenfors, R.K. Tuominen, M. Lepantalo, O. Carpen, J. Parkkinen, and H. Rauvala Regulation of monocyte migration by amphoterin (HMGB1) Blood 104 4 2004 1174 1182
98. G. Rudofsky Jr., B. Isermann, T. Schilling, S. Schiekofer, M. Andrassy, J.G. Schneider, M. Morcos, P.M. Humpert, A.A. Sayed, S. Witte, W. Renn, M. Pfohl, A. Hamann, V. Nosikov, E. Schleicher, H.U. Haring, G. Rudofsky, E. Ritz, P.P. Nawroth, and A. Bierhaus A 63 bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes Exp. Clin. Endocrinol. Diab. 112 2004 135 141
99. T.P. Salazar-Mather, T.A. Hamilton, and C.A. Biron A chemokine-to- cytokine-to-chemokine cascade critical in antiviral defense J. Clin. Invest. 105 2000 985 993
100. T.P. Salazar-Mather, J.S. Orange, and C.A. Biron Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways J. Exp. Med. 187 1998 1 14
101. M. Salio, M. Cella, W. Vermi, F. Facchetti, M.J. Palmowski, C.L. Smith, D. Shepherd, M. Colonna, and V. Cerundolo Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions Eur. J. Immunol. 33 2003 1052 1062
102. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
103. H. Schindler, M.B. Lutz, M. Rollinghoff, and C. Bogdan The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4 J. Immunol. 166 2001 3075 3082
104. A. Schmidt, J.R. Ortaldo, and R.B. Herberman Inhibition of human natural killer cell reactivity by exogenous adenosine 5′-triphosphate J. Immunol. 132 1984 146 150
105. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, J. Zhang, R. Cao, S.D. Yan, J. Brett, and D. Stern Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes J. Clin. Invest. 96 1995 1395 1403
106. M. Schnurr, T. Toy, P. Stoitzner, P. Cameron, A. Shin, T. Beecroft, I.D. Davis, J. Cebon, and E. Maraskovsky ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling Blood 102 2003 613 620
107. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
108. M. Shodell, and F.P. Siegal Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing Scand. J. Immunol. 56 2002 518 521
109. N. Strbo, S. Oizumi, V. Sotosek-Tokmadzic, and E.R. Podack Perforin is required for innate and adaptive immunity induced by heat shock protein gp96 Immunity 18 2003 381 390
110. A. Taguchi, D.C. Blood, G. del Toro, A. Canet, D.C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M.A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D.M. Stern, and A.M. Schmidt Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
111. H. Tahara, and M.T. Lotze Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer Gene Ther. 2 1995 96 106
112. H. Tahara, L. Zitvogel, W.J. Storkus, H.J. Zeh III, T.G. McKinney, R.D. Schreiber, U. Gubler, P.D. Robbins, and M.T. Lotze Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J. Immunol 154 1995 6466 6474
113. M. Takada, T. Koizumi, H. Toyama, Y. Suzuki, and Y. Kuroda Differential expression of RAGE in human pancreatic carcinoma cells Hepatogastroenterology 48 2001 1577 1578
114. D. Tamiolakis, C. Simopoulos, A. Cheva, M. Lambropoulou, A. Kotini, T. Jivannakis, and N. Papadopoulos Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast Eur. J. Gynaecol. Oncol. 23 2002 433 436
115. S. Tasca, G. Tambussi, S. Nozza, B. Capiluppi, M.R. Zocchi, L. Soldini, F. Veglia, G. Poli, A. Lazzarin, and C. Fortis Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis Aids 17 2003 2291 2298
116. A.W. Thomson, and M.T. Lotze The Cytokine Handbook 2003 Academic Press London
117. C.J. Treutiger, G.E. Mullins, A.S. Johansson, A. Rouhiainen, H.M. Rauvala, H. Erlandsson-Harris, U. Andersson, H. Yang, K.J. Tracey, J. Andersson, and J.E. Palmblad High mobility group 1 B-box mediates activation of human endothelium J. Intern. Med. 254 2003 375 385
118. G. Trinchieri, S. Pflanz, and R.A. Kastelein The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses Immunity 19 2003 641 644
119. P.L. Triozzi, R. Khurram, W.A. Aldrich, M.J. Walker, J.A. Kim, and S. Jaynes Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer Cancer 89 2000 2646 2654
120. Vakkila, J., Lotze, M., in press. Inflammation and necrosis promote tumor growth. Nat. Rev. Immunol.
121. D. Valteau-Couanet, C. Leboulaire, K. Maincent, M. Tournier, O. Hartmann, J. Benard, F. Beaujean, C. Boccaccio, L. Zitvogel, and E. Angevin Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients Blood 100 2002 2554 2561
122. K.G. Veenstra, Z.L. Jonak, S. Trulli, and J.A. Gollob IL-12 induces monocyte IL-18 binding protein expression via IFN-gamma J. Immunol. 168 2002 2282 2287
123. W. Vermi, R. Bonecchi, F. Facchetti, D. Bianchi, S. Sozzani, S. Festa, A. Berenzi, M. Cella, and M. Colonna Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas J. Pathol. 200 2003 255 268
124. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama, and K.J. Tracey HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
125. H. Wang, H. Yang, and K.J. Tracey Extracellular role of HMGB1 in inflammation and sepsis J. Intern. Med. 255 2004 320 331
126. H. Yang, M. Ochani, J. Li, X. Qiang, M. Tanovic, H.E. Harris, S.M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, C.J. Czura, J. Roth, H.S. Warren, M.P. Fink, M.J. Fenton, U. Andersson, and K.J. Tracey Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc. Natl. Acad. Sci. U.S.A. 101 2004 296 301
127. K. Yoshida, S. Ueno, T. Iwao, S. Yamasaki, A. Tsuchida, K. Ohmine, R. Ohki, Y.L. Choi, K. Koinuma, T. Wada, J. Ota, Y. Yamashita, K. Chayama, K. Sato, and H. Mano Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma Cancer Sci. 94 2003 263 270
128. T. Yoshimoto, H. Okamura, Y.I. Tagawa, Y. Iwakura, and K. Nakanishi Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells 94 1997 3948 3953
129. H.J. Zeh III, S. Hurd, W.J. Storkus, and M.T. Lotze Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer J. Immunother. 14 1993 155 161
130. W. Zou, V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, T. Isaeva, S. Wei, R. Krzysiek, I. Durand-Gasselin, A. Gordon, T. Pustilnik, D.T. Curiel, P. Galanaud, F. Capron, D. Emilie, and T.J. Curiel Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells Nat. Med. 7 2001 1339 1346